TITXF Financials 07/16/2014 13:37:00
Titan Medical Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 5,190 4,658 12,270 1,584
Sales, General and Admin. 3,373 3,087 3,566 2,120
Non-Recurring Items - - - -
Other 290 133 96 42
Operating Income (8,853) (7,878) (15,932) (3,746)
Income From Continuing Operations
Add'l Income/Expense Items 59 87 93 34
Earnings Before Interest and Tax (8,794) (7,791) (15,838) (3,712)
Interest Expense - - - -
Earnings Before Tax (8,794) (7,791) (15,838) (3,712)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (8,794) (7,791) (15,838) (3,712)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (8,794) (7,791) (15,838) (3,712)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (8,794) (7,791) (15,838) (3,712)